Privium Fund Management B.V. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 3 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Privium Fund Management B.V. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,364,443
+11.3%
228,493
+0.9%
3.08%
+57.1%
Q2 2023$9,311,128
+42.5%
226,493
+23.9%
1.96%
-10.5%
Q1 2023$6,532,307
+17.5%
182,773
+22.8%
2.19%
+4.1%
Q4 2022$5,557,941
-15.6%
148,8070.0%2.11%
-11.9%
Q3 2022$6,589,000
-1.2%
148,807
-17.4%
2.39%
+8.4%
Q2 2022$6,668,000
-0.0%
180,1070.0%2.21%
+49.8%
Q1 2022$6,671,000
-65.3%
180,107
-71.4%
1.48%
-61.4%
Q4 2021$19,246,000630,1993.82%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders